Skip to main content
. 2023 Jan 28;24(3):2513. doi: 10.3390/ijms24032513
2-AG 2-arachidonoylglycerol
5-HT1A 5-hydroxytryptamine receptor subtype 1A
AD Alzheimer’s disease
Ads Autoimmune diseases
AEA N-arachidonoylethanolamide/anandamide
BBB Blood brain barrier
cAMP Cyclic adenosine monophosphate
CAT Catalase
CB1 Cannabinoid receptors 1
CB2 Cannabinoid receptors 2
CBD Cannabidiol
CBG Cannabigerol
CGD Chronic granulomatous diseases
CNS Central nervous system
COX Cyclooxygenase
CRC Colorectal cancer
DAGLα/β Diacylglycerol lipase-α and -β
DAGs Diacylglycerols
EAE Autoimmune encephalomyelitis
ECs Endocannabinoids
ECS Endocannabinoid system
FAAH Fatty acid amide hydrolase
GPCRs G-protein-coupled receptor
GPR55 G-protein-coupled receptor 55
GPx Glutathione peroxidase
GSH Glutathione
H2O2 Hydrogen peroxide
HD Huntington’s disease
HO• Hydroxyl radical
IB Inflammatory bowel disease
iNOS Inducible nitric oxide synthase
IS Immune system
LDL Low-density lipoproteins
LPS Lipopolysaccharide
MAGL Monoacyl glycerol lipase
MAPK Mitogen-activated protein kinase
MS Multiple sclerosis
NADPH Nicotinamide adenine dinucleotide phosphate
NAPE N-arachidonoyl phosphatidyl ethanolamine
NMDAr N-methyl-D-aspartate receptor
NOX1 NADPH oxidase 1
NOX2 NADPH oxidase 2
NOX4 NADPH oxidase 4
O2 •− Superoxide anion
PD Parkinson’s disease
PI3K Phosphoinositide 3-kinase
PNS Peripheral nervous system
PPARs Peroxisome proliferator-activated receptors
RA Rheumatoid arthritis
Redox Reduction-oxidation
RNS Reactive nitrogen species
ROS Reactive oxygen species
SCBs Synthetic cannabinoids
SOD Superoxide dismutase
T1DM Type 1 diabetes mellitus
THC Delta-9-tetrahydrocannabinol
TLR4 Toll-like receptor 4
TRPV1 Transient receptor potential cation channel subfamily V member 1
VLDL Low density lipoprotein
XO Xanthine oxidase